Study | Country | Sample size | NAFLD diagnosis | Patients source | Date | Study design | Colorectal cancer diagnosis | Adjusted confounding factors | Study quality |
---|---|---|---|---|---|---|---|---|---|
Chen et al. 2018 [26] | China | 764 | Ultrasonography | Community | 2014–2016 | Cross-sectional | Colonoscopy | Age, sex, smoking, alcohol intake, metabolic syndrome | Good |
Ahn et al. 2017 [25] | South Korea | 26,540 | Ultrasonography | Community | 2003–2012 | Cross-sectional | Histology | Age, sex, BMI, smoking, alcohol intake, first degree family history of colorectal cancer, aspirin use, fasting plasma glucose, total cholesterol, triglycerides, systolic blood pressure, use of any hypoglycemic, anti-hypertensive drugs or use of statin | Good |
Chen et al. 2017 [47] | China | 3686 | Ultrasonography | Hospital | 2007–2014 | Cross-sectional | Endoscopy | Age, CEA, stage, tumor location, and tumor differentiation | Good |
Pan et al. 2017 [31] | China | 1793 | Ultrasonography | Community | 2011–2015 | Cross-sectional | Colonoscopy | Age, sex, ALT, uric acid, metabolic syndrome | Good |
Lee et al. 2016 [28] | South Korea | 44,221 | Ultrasonography | Community | 2010–2011 | Cross-sectional | Colonoscopy | Age, sex, BMI, smoking, family history of colorectal cancer, aspirin use, hypertension, diabetes mellitus | Good |
Lin et al. 2014 [30] | China | 2314 | Ultrasonography | Hospital | 2007–2011 | Cross-sectional | Colonoscopy | Age, sex, BMI, hypertension, plasma triglycerides, uric acid, ALT, albumin, hemoglobin, platelet count | Fair |
Wong et al. 2011 [36] | China | 380 | 1H-MRS/Liver biopsy | Community/Hospital | 2008–2010 | Cross-sectional | Colonoscopy | Age, sex, BMI, smoking, family history of colorectal cancer, hypertension, diabetes mellitus | Good |
Stadlmayr et al. 2011 [35] | Austria | 1211 | Ultrasonography | Hospital | 2007–2009 | Cross-sectional | Colonoscopy | Age, sex, BMI, glucose intolerance status (impaired fasting glycaemia or diabetes mellitus) | Good |
Hwang et al. 2010 [34] | South Korea | 2917 | Ultrasonography | Hospital | 2007 | Cross-sectional | Colonoscopy | Age, sex, smoking, hypertension, diabetes mellitus, metabolic syndrome | Good |
Allen et al. 2019 [21] | USA | 276 | HCIDA/ICD-9 | Community | 1997–2016 | Cohort | ICD-9 | NA | Good |
Hamaguchi et al. 2019 [27] | Japan | 15,926 | Ultrasonography | Community | 2004–2016 | Cohort | Endoscopy | Sex, age and lifestyle factors including smoking habits, alcoholic consumption and physical activities and diabetes | Good |
Kim et al. 2017 [24] | South Korea | NA | Ultrasonography | Community | 2004–2005 | Cohort | Pathology | Demographic and metabolic factors | Good |
Yang et al. 2017 [32] | South Korea | 882 | Ultrasonography/ computed tomography | Hospital | 2009–2013 | Cohort | Colonoscopy | Age, sex, smoking, hypertension, diabetes mellitus, use of aspirin or lipid-lowering agents; imaging for diagnosis of NAFLD | Fair |
Huang et al. 2013 [33] | South Korea | 1522 | Ultrasonography | Hospital | 2003–2010 | Cohort | Colonoscopy | Age, sex, BMI, smoking, hypertension, diabetes mellitus, metabolic syndrome | Fair |
Lee et al. 2012 [29] | South Korea | 5517 | Ultrasonography | Hospital | 2002–2006 | Cohort | Colonoscopy | Age, BMI, smoking, hypertension, dyslipidemia, fasting glucose level | Fair |